CNSL Statistics
Total Valuation
Cambridge Nutritional Sciences has a market cap or net worth of GBP 7.85 million. The enterprise value is 3.41 million.
Market Cap | 7.85M |
Enterprise Value | 3.41M |
Important Dates
The last earnings date was Friday, November 22, 2024.
Earnings Date | Nov 22, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Cambridge Nutritional Sciences has 237.95 million shares outstanding. The number of shares has decreased by -6.43% in one year.
Current Share Class | n/a |
Shares Outstanding | 237.95M |
Shares Change (YoY) | -6.43% |
Shares Change (QoQ) | +0.35% |
Owned by Insiders (%) | 0.43% |
Owned by Institutions (%) | 53.60% |
Float | 230.65M |
Valuation Ratios
The trailing PE ratio is 41.61.
PE Ratio | 41.61 |
Forward PE | n/a |
PS Ratio | 0.81 |
PB Ratio | 0.68 |
P/TBV Ratio | n/a |
P/FCF Ratio | 17.81 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 162.45, with an EV/FCF ratio of 7.74.
EV / Earnings | 19.61 |
EV / Sales | 0.38 |
EV / EBITDA | 162.45 |
EV / EBIT | n/a |
EV / FCF | 7.74 |
Financial Position
The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.01.
Current Ratio | 5.13 |
Quick Ratio | 4.60 |
Debt / Equity | 0.01 |
Debt / EBITDA | 3.76 |
Debt / FCF | 0.18 |
Interest Coverage | -13.41 |
Financial Efficiency
Return on equity (ROE) is 1.85% and return on invested capital (ROIC) is -1.93%.
Return on Equity (ROE) | 1.85% |
Return on Assets (ROA) | -1.35% |
Return on Capital (ROIC) | -1.93% |
Revenue Per Employee | 95,468 |
Profits Per Employee | 1,851 |
Employee Count | 94 |
Asset Turnover | 0.66 |
Inventory Turnover | 3.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.69% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +37.69% |
50-Day Moving Average | 3.42 |
200-Day Moving Average | 3.52 |
Relative Strength Index (RSI) | 47.95 |
Average Volume (20 Days) | 527,386 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cambridge Nutritional Sciences had revenue of GBP 8.97 million and earned 174,000 in profits. Earnings per share was 0.00.
Revenue | 8.97M |
Gross Profit | 5.66M |
Operating Income | -295,000 |
Pretax Income | -243,000 |
Net Income | 174,000 |
EBITDA | -76,000 |
EBIT | -295,000 |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 4.52 million in cash and 79,000 in debt, giving a net cash position of 4.44 million or 0.02 per share.
Cash & Cash Equivalents | 4.52M |
Total Debt | 79,000 |
Net Cash | 4.44M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 9.54M |
Book Value Per Share | 0.05 |
Working Capital | 6.04M |
Cash Flow
In the last 12 months, operating cash flow was 616,000 and capital expenditures -175,000, giving a free cash flow of 441,000.
Operating Cash Flow | 616,000 |
Capital Expenditures | -175,000 |
Free Cash Flow | 441,000 |
FCF Per Share | 0.00 |
Margins
Gross margin is 63.02%, with operating and profit margins of -3.29% and 1.94%.
Gross Margin | 63.02% |
Operating Margin | -3.29% |
Pretax Margin | -2.71% |
Profit Margin | 1.94% |
EBITDA Margin | -0.85% |
EBIT Margin | -3.29% |
FCF Margin | 4.91% |
Dividends & Yields
Cambridge Nutritional Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.43% |
Shareholder Yield | 6.43% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on August 31, 2007. It was a reverse split with a ratio of 0.025.
Last Split Date | Aug 31, 2007 |
Split Type | Reverse |
Split Ratio | 0.025 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |